Armando Vega-López

9PUBLICATIONS
31CO-AUTHORS
Environmental biogeochemistryMolecular targetsPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 30, 2025
Neurotransmission disruption in wild Chirostoma jordani from Lake Zumpango linked to alkylphenols and their derivatives.

Genaro Atonal-Brioso, Israel Lara-Vega, Minerva Nájera-Martínez

|Aug 14, 2025
Pentoxifylline and Norcantharidin Synergistically Suppress Melanoma Growth in Mice: A Multi-Modal In Vivo and In Silico Study.

Israel Lara-Vega, Minerva Nájera-Martínez, Armando Vega-López

|Feb 13, 2025
Evaluation of a Norcantharidin Nanoemulsion Efficacy for Treating B16F1-Induced Melanoma in a Syngeneic Murine Model.

Gabriel Martínez-Razo, Patrícia C Pires, Angélica Avilez-Colin

|Oct 26, 2024
The Generation of ROS by Exposure to Trihalomethanes Promotes the IκBα/NF-κB/p65 Complex Dissociation in Human Lung Fibroblast.

Minerva Nájera-Martínez, Israel Lara-Vega, Jhonatan Avilez-Alvarado

|May 25, 2024
Pentoxifylline and Norcantharidin Modify p62 Expression in 2D and 3D Cultures of B16F1 Cells.

José Luis González-Quiroz, Juan Moisés Ocampo-Godínez, Victoria Noemi Hernández-González

|Oct 28, 2023
Tumor-Infiltrating iNKT Cells Activated through c-Kit/Sca-1 Are Induced by Pentoxifylline, Norcantharidin, and Their Mixtures for Killing Murine Melanoma Cells.

Maximiliano V M Correa-Lara, Israel Lara-Vega, Minerva Nájera-Martínez

Pageof 2